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Professor Sir Philip Randle FRCP, FMedSci, FRS was a
towering figure, both intellectually and physically, in
diabetes research. During his distinguished career he made
substantial contributions to our knowledge of both insulin
action and insulin secretion.
Professor Sir Philip Randle died in Oxford at the age of
80 years on 26 September 2006. He was one of the
foremost researchers into aspects of mammalian metabo-
lism, and many of his findings have had a direct bearing on
the understanding and treatment of diabetes.
Philip Randle was born in 1926 in Nuneaton (Warwick-
shire, UK). His father was a baker and his mother a music
teacher. He went to the local King Edward VI Grammar
School before studying natural sciences at Cambridge
University. In his final year (1947), he obtained a first
class degree in Biochemistry—a subject still in its infancy
at that time. It was at this time that he first developed his
lifelong interest in insulin and changes in metabolism that
occur in diabetes. He moved to University College Hospital
Medical School (London, UK) and completed his medical
studies before returning to Cambridge as a research student
of Professor Sir Frank Young. He was awarded a PhD in
1955 for studies on the metabolic actions of insulin.
Immediately, he was appointed to a Lectureship in the
Biochemistry Department at Cambridge University and
continued his studies into various aspects of insulin action
and the control of metabolism, particularly in muscle.
These studies culminated in a series of very influential
papers published in 1963 and 1964 with a group of
outstanding research students and fellows: Eric Newsholme,
Nick Hales, Peter Garland and Hal Coore. Taken together,
these papers have been cited more than 10,000 times and are
still being cited frequently to this day. They set out the basic
evidence both for the ‘glucose–fatty acid cycle’ of fuel
selection by tissues (often referred to as the ‘Randle cycle’)
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[1] and for the ‘substrate-site hypothesis,’ the means
whereby increases in blood glucose cause insulin release
from the beta cells in the pancreas [2]. Much of the research
of Philip Randle over the next three decades was concerned
with uncovering in detail the basic biochemical mecha-
nisms involved in these two fundamental processes.
Crucially, the glucose–fatty acid cycle recognises that,
given a choice between glucose and fatty acids, muscle uses
the fatty acids as the main energy source. Philip Randle and
his colleagues went on to reason that increased fatty acid
use might be responsible for the insulin resistance associ-
ated with obesity and type 2 diabetes. The fundamental
importance of the glucose–fatty acid cycle in the normal
physiology of muscle and other tissues is now widely
accepted [3]. However, it is now clear that many extracel-
lular factors also influence the relationship, including
insulin and other long-recognised hormones, plus many
newly recognised potent cell regulators, such as leptin,
adiponectin and resistin, which are released by fat, muscle
and other cells and are not part of the traditional endocrine
system. In much the same way, it is now evident that the
insulin resistance associated with obesity/type 2 diabetes
involves a remarkable complex array of changes, of which
increased fatty acid utilisation is one of a number of
candidates that may initiate insulin resistance. Philip Randle
was fully aware of these developments, and this is well
illustrated in a detailed review written by him on the topic
in 1998 when he was 72 years old, 35 years after the birth
of the Randle cycle [4].
The substrate-site hypothesis of insulin secretion was
devised following truly ground-breaking studies on pancre-
atic pieces conducted by Philip Randle and Hal Coore [2],
in which insulin secretion was measured by a new
radioimmunoassay, which was also developed within the
Randle group, by Nick Hales [5]. It was generally thought
at the time that glucose stimulated insulin secretion by
binding to a receptor similar to a hormone receptor. In
contrast, on the basis of their observations on the specificity
of the insulin secretory response to sugars in vitro, Coore
and Randle hypothesised that it was the actual metabolism
of glucose by the beta cells in the pancreas that was
coupled to the release of insulin. At the time this model was
suggested it was not possible to test it directly. However,
when methods became available for the study of the
metabolism of isolated islets of Langerhans, evidence to
support the hypothesis was soon forthcoming from the
Randle laboratory [6, 7]. Subsequent studies, including a
long series of investigations by Steve Ashcroft with Philip
Randle, fully confirmed the substrate-site hypothesis and
have uncovered the underlying biochemical mechanisms.
Philip Randle moved to Bristol in 1964 and founded a
new Department of Biochemistry. This was a period of
expansion in UK universities, but the rapid development of
the Department of Biochemistry under his leadership was
quite remarkable. Bristol University had had Medical,
Veterinary and Dental Schools for many years and was
also strong in many areas of medical and other sciences.
However, there was no biochemistry department. Within
7 years, the new department was one of the strongest in the
UK, both in research and teaching—a position it holds to
this day. How did Philip Randle do this? In hindsight, it is
easy to see that his most important action was a whole
series of inspired academic appointments across the full
range of the discipline of biochemistry. However, it was
also necessary for Philip Randle to ensure that the new
department had its fair share of space and investment within
the university. His expansionist plans did not always get the
instant support of old-established departments, who natu-
rally saw the new department as a serious threat to their
own plans! Philip Randle’s physical presence (more than
2 m tall), intellect, booming voice and strong pipe smoke
undoubtedly helped in diminishing the more conservative
forces that he had to overcome at that critical period in the
department’s development.
During the 12 years that Philip Randle stayed in Bristol,
his personal research became focused on two areas—the
control of insulin secretion (largely with Steve Ashcroft)
and the regulation of an enzyme, pyruvate dehydrogenase,
that plays a central role in the selection of fuels in muscle
and other cells (often with Dick Denton). Despite his many
responsibilities, substantial progress was made in both
areas. This included the first strong evidence that glucose
metabolism was essential for the initiation of increased
insulin secretion and that insulin activated pyruvate
dehydrogenase activity in adipose tissue (important in the
increased conversion of carbohydrate into fat brought about
by the hormone).
In 1975, Philip Randle moved to Oxford to found
another new department, this time the Department of
Clinical Biochemistry. This department was very different
from the large department he had developed in Bristol.
Instead of more than 20 established academic staff
members and their research groups, covering the full range
of modern biochemistry, it had only four academic staff
members, two of whom were Philip Randle himself and
Steve Ashcroft, who moved from Bristol with him. This
new department focused very successfully on diabetes-
related research, and Philip Randle’s own major interest
continued to be the regulation of pyruvate dehydrogenase,
mainly in muscle. Philip Randle retired from this position
in 1993. The major scientific meeting held in Oxford that
year in his honour, entitled ‘Metabolic fuel selection in
health and disease’, was an eloquent testimony of the
esteem in which he was held throughout the world.
Over the years, Philip Randle took on many other
responsibilities in addition to those in his universities.
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These included appointments as Chairman of a large
number of research committees and boards for Diabetes
UK, the Medical Research Council and the British Heart
Foundation, Vice-President of the Royal Society and
President of the Biochemical Society. He played an
important role in the establishment of the European
Association for the Study of Diabetes (EASD) and was a
member of its Council from 1968–1972, and its President
from 1977–1980. In the early 1980s, Philip Randle devoted
great energy to advising the government on aspects of food
policy. In particular, he chaired the influential Food Policy
Panel on Diet and Cardiovascular Disease. This panel
developed recommendations on lowering intakes of satu-
rated fat, simple sugars and salt [8]. This advice is still
accepted today, but sadly is not always heeded.
Among the many honours that Philip Randle received
were the Banting Lecture of Diabetes UK (1965), first
recipient of the Minkowski Prize of the EASD (1966), the
Humphrey Davy Rolleston Lecture of the Royal College of
Physicians (1983), election to Fellow of the Royal Society
(1983), Knight Bachelor (1985) and a Founder Fellow of
the Academy of Medical Sciences (1998). In connection
with the Minkowski Prize, he wrote an important article for
Diabetologia [9].
He had a massive and enduring influence on the PhD
students and young research fellows passing through his
laboratory. To date, three of his research students have
become Fellows of the Royal Society and the number now
holding university chairs or comparable positions in the
pharmaceutical industry is well into double figures.
Although the death of Philip Randle is truly an end of an
era, he has left a substantial legacy of both the department
he started in Bristol as well a worldwide network of
researchers whose careers were influenced in a very
substantial way by the time spent under his supervision.
Philip Randle was supported in all his activities by his
wife Elizabeth, whom he married in 1952 and who sadly
died 2 years ago. He also suffered the loss of his son, Peter,
who died still a teenager in 1971 and a daughter, Susan,
who died in 2005. He is survived by two daughters, Sally
and Rosalind, and four grandchildren.
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